Navigation Links
BMC to Actively Defend against Curative in Patent Fight
Date:7/18/2014

BEIJING, July 18, 2014 /PRNewswire/ -- On June 24th, 2014, BMC Medical Co., Ltd. (hereinafter referred to as "BMC") received a complaint submitted to the Suzhou Intermediate People's Court by Curative Medical Technology (Suzhou) Inc. (hereinafter referred to as "Curative"). Curative accused BMC of violating its patent ZL200610080596.6. (sound-absorbing mechanism and the Positive Airway Pressure device that adopts this mechanism).

Logo - http://photos.prnasia.com/prnh/20140423/0861402591

After receiving the complaint, BMC took active measures to deal with Curative's lawsuit and consulted YUHONG Intellectual Property Law Firm (hereinafter referred to as "YUHONG") on the patent in dispute. After carrying out comprehensive research and analysis, YUHONG concludes that the stability of the patent right of No. ZL200610080596.6 has serious problems. According to Article 47 of the Patent Law of the PRC, "any patent right that has been declared invalid shall be deemed to be non-existent from the beginning." At present, the Chinese Patent Re-examination Board has accepted BMC's invalidity application against the patent at issue. Meanwhile, BMC has hired a professional team of patent lawyers to respond to, and cope with, this lawsuit so as to protect the company's legitimate rights.

As China's leading provider of home-use sleep therapy devices and services, BMC adheres to the mission of efficient product research and development as well as constant technology innovation, quality improvement, and cost reduction. It now possesses a large number of independently developed intellectual property rights, and its products have been sold to more than 80 countries across the world. BMC aims to become the world's leader of home-use sleep therapy devices and services. For more information about BMC, please visit http://www.bmc-medical.com.


'/>"/>
SOURCE BMC Medical Co., Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. Essential Medical Dismisses Patent Case against Masimo and Cercacor
3. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
4. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
5. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
6. Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager
7. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
8. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. South Carolinas Stop-Sale System Achieves Significant Results In Battle Against Meth
11. Tennessee Stop-Sale System Achieves Significant Results In Battle Against Meth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets ... Devices - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Uterine cancer Drugs Price Analysis and Strategies ... cancer market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Uterine cancer ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... ... Philpart, senior director at PolicyLink, will be the keynote speaker at its second ... and Men of Color Framework, which develops comprehensive strategies to create and expand ...
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care ... the secure exchange of data across industry solutions, Fogo Data Centers announces the launch ... community. A healthy community is one in which all systems work well, work ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... ... February 20, 2017 , ... Scrubbing in for his first ... Dr. Christopher Pezzi remembers the excitement of the surgeon training him. , “He was ... to do this? Don’t tell anyone, but I would do it for free,’” Dr. ...
Breaking Medicine News(10 mins):